NANDROLONE DECANOATE 1 ml / 200 mg
Nandrolone Decanoate USP 29, Ph.Eur.5.5 Micronized grade
Formula: CJSAOJ (CAS-360-70-3, ATC-A14AB01 ;S01 XA11)
MolecularWeight: 428.6 gm/mol Active life: 15 days Detection time: upto18months Anabolic/Androgcnic ratio: 125:37
Nandrolone Decanoate is a steroid compound that is described chemically as 17(3- hydroxyestr-4-en-3-one decanoate. It occurs as a white to creamy-white fine crystalline powder, odourless or may have a slight odour. Practical insoluble in water, soluble in alcohol, in acetone, in chloroform and in vegetable.
DECA 200* is a sterile solution of 200 mg/ml Nandrolone Decanoate USP29, Ph.Eur.5.5, Miglyol 840, Ethyl oleate, Benzyl benzoate, Benzyl alcohol.
DECA 200“ is available as a sterile solution of Nandrolone Decanoate, a long- action anabolic agent,for only intramuscular injection.
Anabolic steroids are synthetic derivatives of testosterone. Certain clinical effects and adverse reactions demonstrate the androgenic properties of this class of drugs. No dissociation of androgenic and anabolic potency has been demonstrated clinically for any anabolic steroid although there is some suggestion from animal studies that such dissociation may be possible.
The actions of anabolic steroids are therefore similar to those of male sex hormones with the possibility of causing serious disturbances of growth and sexual development if given to young children. Anabolic steroids suppress the gonadotropic functions of the pituitary and may exert a direct effect upon the testes.
During exogenous administration of anabolic androgens, endogenous testosterone release is inhibited through inhibition of pituitary luteinizing hormone (LH). At large doses, spermatogenesis may be suppressed through feed back inhibition of pituitaryfollicle-stimulation hormone (FSH).
Anabolic steroids increase low-density lipoproteins and decrease high- density lipoproteins. These changes revert to normal on discontinuation of treatment.
INDICATIONS AND USAGE:
DECA 200®is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. Surgically induced nephric patients have been reported to be less responsive. DecaNan® is used alone or as an adjunct in the treatment of anemia secondary to bone marrow failure, breast cancer in postmenopausal women, non-small cell lung cancer,and postmenopausal osteoporosis.
1. Known or suspected carcinoma of the prostate or the male breast.
2. Carcinoma of the breast in females with hypercalcemia (androgenic
anabolic steroids may stimulate osteolytic bone resorption).
3. Pregnancy, because of possible masculinization of the female fetus. Androgenic anabolic steroids are known to cause embryotoxicity, fetotoxicity, and masculinization of female animal offspring. DecaNan® is contraindicated in women who are or may become pregnant.
If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, she should beapprisedofthepotentialhazardtothefetus.
4. Nephrosis or the nephrotic phase of nephritis.